Herantis Pharma’s Annual Report 2014 published

Herantis Pharma's Annual Report 2014 published
Herantis Pharma Plc
Company release 24 March 2015 at 10:00 am

Herantis  Pharma Plc's Annual Report for the year 2014 has been published today.
The  Annual Report contains financial statements and  the report of the Board of
Directors.  The Annual Report is available in  PDF format in Finnish and English
as   an   appendix   to   this   release  and  on  the  company's  web  site  at
https://herantis.com in section Investors - Financial information.

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225

About Herantis Pharma Plc

Herantis Pharma Plc is a pharmaceutical company specialised in new drug research
and  development. The company  focuses on diseases  with an unmet clinical need.
These  diseases include for  example dry eye  syndrome, Parkinson's disease, and
secondary  lymphedema. We believe our drugs are the first or best in their class
and have the potential to change treatment strategies of diseases. The shares of
Herantis  Pharma Plc are  listed on the  First North Finland  marketplace run by
NASDAQ Helsinki stock exchange.